ARMP · Armata Pharmaceuticals, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. While management believes this plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within our control and cannot be assessed as being probable of occurring.”View the 10-Q filed Aug 12, 2026
Positioning
Aug 21, 2026 · 4 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | 287.3% | 0.978 | — | $0.50 | — | — | 1 | 1 | |
| 8 | 4 | 212.1% | 0.398 | $0.40 | $0.35 | -0.365 | 771.8% | 10 | 20 | |
| 5 | 1 | 452.4% | 0.244 | $0.21 | $1.64 | -0.88 | 319.8% | 1 | 23 | |
| 10 | 2 | 802.4% | 0.35 | $0.95 | — | -0.979 | 316.8% | — | 0 | |
| 12 | 10 | 775.6% | 0.242 | $0.75 | — | -0.934 | 496.8% | — | 0 | |
| 1 | 1 | 1565.4% | 0.593 | $0.15 | — | -0.939 | 568% | — | 0 | |
| 0 | — | — | — | — | — | -0.984 | 491.6% | — | 0 | |
| 0 | — | — | — | — | — | — | — | — | 0 | |
| 0 | — | — | — | — | — | — | — | — | 0 | |
| 1 | 1 | — | — | $0.15 | — | -0.986 | 600.6% | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Apr 29, 2026–Aug 10, 2026; 11 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.